QED claims to meet UK govt
QED Consulting, the UK-based developers of the QED Bio-Entrepreneur School, claims that its project meets the requirements of the UK's Chancellor of the Exchequer, Gordon Brown, for the encouragement of bio-scientific enterprise in the country. The Nottingham-headquartered firm is offering 30 free places on its February 28-29 course, in partnership with the BioCity Nottingham center.
Martijn Mugge, a spokesman for the firm, said: "the Chancellor talks of transforming our strength in scientific research into successful products and jobs. This school is just one contribution to what Gordon Brown refers to as developing our commericial flexibility and our level of creativity and entrepreneurship in the bioscience sector." Details of the QED event in Nottingham can be found on-line at: www.bioentrepreneur.com.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze